Chase AIPricingFAQs
Display currency
Loading news…

Ribometrix

ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals.
Greenville, South Carolina, United States Founded 2014 11-50 employees For Profit

Ribometrix is a platform therapeutics company that discovers small molecule drugs to treat human diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
24

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private
Valuation range
$100M to $500M

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
4
IT spend
$359K

Company Info

Founded
2014
Employees
11-50
Operating status
Active
Company type
For Profit
Org types
company
Founders
1
News articles
24
HQ
Greenville, South Carolina, United States
Region
East Coast, Southern US
Diversity spotlight
Women Founded

Signals & Scores

Heat score
Medium
Growth score
Low
Trend (7d)
0.9
Trend (30d)
2.6
Trend (90d)
-0.5
Last leadership hire
Jan 9, 2025

Key People at Ribometrix

CEO
Co-Founder & Vice President, RNA Biology
Chief Scientific Officer
24
professional contacts at Ribometrix
Contact execs at Ribometrix

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Ribometrix

Loading news…

FAQs about Ribometrix

People who checked this page also checked these

Browse the full Acquirezy directory.
Ribometrix - Company Profile, Full Acquisitions List, Funding and Investments